NOS2 and COX2 impact the spatial landscape of CD8&lt;sup&gt;+&lt;/sup&gt; T cells in ER-breast cancer, providing novel mechanistic insight that drives tumor progression and poor survival. Here, NOS2 is linked to breast cancer.